secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0000950170-24-040345
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma launches $75M common stock offering at $5.18/share
------------------------------------------------------------------

- 14,478,764 shares offered at $5.18/share; gross proceeds ~$75M.
- Underwriting agreement with BofA Securities; closing expected April 4, 2024.
- Net proceeds for general corporate purposes including R&D and working capital.
- Offering is dilutive to existing shareholders; trading symbol STRO on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017024040345/0000950170-24-040345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017024040345/stro-20240402.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-040345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer